KEIFERX LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.keiferx.com
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
Phase 3
Not yet recruiting
- Conditions
- Alzheimer Disease
- Interventions
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- KeifeRx, LLC
- Target Recruit Count
- 1275
- Registration Number
- NCT05143528
© Copyright 2025. All Rights Reserved by MedPath